BANK OF AMERICA CORP /DE/ - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 79 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 2.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,527,321
+9.4%
110,243
-21.3%
0.00%
Q2 2023$2,310,546
-64.0%
140,118
-61.0%
0.00%
-100.0%
Q1 2023$6,416,442
-17.2%
359,666
+35.1%
0.00%0.0%
Q4 2022$7,750,375
+44.8%
266,153
+21.9%
0.00%0.0%
Q3 2022$5,351,000
+2536.0%
218,409
+344.7%
0.00%
Q2 2022$203,000
-55.6%
49,112
+24.0%
0.00%
Q1 2022$457,000
-62.6%
39,615
-67.7%
0.00%
Q4 2021$1,223,000
-54.2%
122,635
-40.0%
0.00%
Q3 2021$2,670,000
+13.9%
204,463
+70.8%
0.00%
Q2 2021$2,344,000
+3.5%
119,678
+12.4%
0.00%
Q1 2021$2,264,000
-15.5%
106,442
+18.1%
0.00%
Q4 2020$2,680,000
-55.6%
90,159
-67.6%
0.00%
-100.0%
Q3 2020$6,032,000
+5.6%
278,380
+8.7%
0.00%0.0%
Q2 2020$5,712,000
+706.8%
256,158
+450.8%
0.00%
Q1 2020$708,000
-38.4%
46,509
-7.1%
0.00%
Q4 2019$1,149,000
+50.2%
50,060
+41.2%
0.00%
Q3 2019$765,000
+30.5%
35,456
+33.1%
0.00%
Q2 2019$586,000
+8.3%
26,633
+34.8%
0.00%
Q1 2019$541,000
-23.2%
19,762
-24.6%
0.00%
Q4 2018$704,000
+98.9%
26,196
+116.3%
0.00%
Q3 2018$354,000
+81.5%
12,111
+93.7%
0.00%
Q2 2018$195,000
+230.5%
6,251
+110.5%
0.00%
Q1 2018$59,000
-44.9%
2,969
-19.8%
0.00%
Q4 2017$107,0003,7020.00%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 909,258$10,475,0003.58%
NEA Management Company, LLC 4,912,306$56,590,0001.64%
RA Capital Management 4,871,067$56,115,0001.22%
Pinz Capital Management, LP 148,475$1,710,0001.07%
Samsara BioCapital, LLC 345,293$3,978,0001.00%
Bell & Brown Wealth Advisors, LLC 117,400$1,352,0000.61%
Rock Springs Capital Management LP 1,237,026$14,251,0000.36%
ACT CAPITAL MANAGEMENT, LLC 27,500$317,0000.34%
Endurant Capital Management LP 105,792$1,219,0000.32%
Baker Brothers Advisors 4,125,062$47,521,0000.27%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders